We’re excited to share that Weave will be both exhibiting and speaking at the AI Drug Discovery & Development Summit, taking place November 18–20, 2025, in Boston, MA. This summit brings together leaders from biotech, pharma, and AI to explore how artificial intelligence is reshaping every stage of the drug development pipeline.

As an exhibitor, Weave will showcase how our AI-native platform supports regulatory teams in developing documents more efficiently and with greater transparency across programs. Whether drafting a new IND or updating a module for a global submission, Weave helps teams write with confidence, stay aligned, and reduce duplication of effort.

We’ll also be joining the speaker lineup to share how teams are using Weave to bring clarity and speed to their regulatory workflows. Stay tuned for talk details and booth info—we’ll share those soon.

Join us in Boston to connect with our team and see how Weave is powering the next era of regulatory writing.
Visit the event page for more information and registration.

Join Weave at AMWA 2025 – Visit Our Booth to Explore the Future of Regulatory Document Development

We’re excited to announce that Weave will be exhibiting at the 2025 Medical Writing & Communication Conference, hosted by the American Medical Writers Association (AMWA). Join us in Phoenix, Arizona, from November 5–8, 2025, to connect with the medical writing community and explore how AI is transforming regulatory content development.

Event Details

Conference: 2025 Medical Writing & Communication Conference
Host: American Medical Writers Association (AMWA)
Dates: November 5–8, 2025
Location: Phoenix, Arizona
Event Website: amwa.org/page/AnnualConference

Join Weave at Regulatory Intelligence Conference Europe 2025 – Sponsor and Featured Speaker

We’re excited to share that Weave will be a sponsor and featured participant at the Regulatory Intelligence Conference Europe 2025, hosted by RAPS and TOPRA. This industry-leading event brings together regulatory intelligence professionals from around the globe to explore policy shifts, data-driven strategies, and the evolving regulatory landscape.

Event Details
Representative: Lindsay Mateo, CCO
Dates: November 3–4, 2025
Location: Hilton London Wembley, London, UK
Event Website: Event Summary

We’re Speaking – Details Coming Soon
A member of the Weave team will be presenting during the conference.
Talk title and time to be announced. Stay tuned for more information about our session, which will focus on the role of AI in regulatory intelligence and documentation workflows.

Visit the Weave Table – #7
As a proud sponsor, we invite you to stop by Table #7 to meet the team and see how The Weave Platform is helping regulatory teams streamline content development, improve traceability, and reduce time-to-deliverable across intelligence and submission workflows.

We’ll be available to discuss:

• Automating repetitive documentation tasks while maintaining human oversight
• Structuring regulatory intelligence outputs with built-in source traceability
• Real-world use cases from life sciences teams using Weave for faster, higher-quality content

Whether you’re modernizing your approach to regulatory operations or exploring AI solutions for intelligence gathering, we’d love to connect in London.

Join Weave at PCT San Diego – Lindsay Mateo Presents on AI-Driven Regulatory Innovation

We’re excited to announce that Lindsay Mateo, Chief Commercial Officer at Weave, will be speaking at the Precision Clinical Trials (PCT) San Diego 2025, a leading event bringing together R&D and regulatory professionals to explore cutting-edge advances in preclinical development, translational science, and digital tools. Join us in San Diego to learn how AI is transforming regulatory writing at the earliest stages of drug development.

Talk Details
Title: Accelerating Clinical Documentation with The Weave Platform: A Time-Lapsed Look at AI-Generated CSR in Under One Hour
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: Thursday, October 30, 2025
Time: 2:30 PM
Location: The Westin San Diego Bayview, San Diego, CA
Event Website: events.precision-globe.com

Session Overview

Clinical submissions demand significant documentation effort, and traditional manual processes are often slow, error-prone, and resource-intensive. This session introduces The Weave Platform, an AI-native solution built to streamline clinical content development across CSRs, protocols, and safety narratives.

Designed specifically for regulatory teams, The Weave Platform automates repetitive workflows while keeping scientific authors in full control—freeing up time for strategy, interpretation, and quality oversight.

What you’ll learn:

• How AI-driven templates accelerate the drafting of key clinical documents
• How built-in automated checks reduce errors and streamline reviews
• How two-click traceability connects content directly to source data
• How AI-assisted workflows preserve accuracy and control

The session will include a time-lapsed video demonstration of a CSR being drafted in under one hour, highlighting how teams can radically improve turnaround times without sacrificing quality or transparency.

Join Weave at PDDP San Diego – Lindsay Mateo Presents on AI-Driven Regulatory Innovation

We’re excited to announce that Lindsay Mateo, Chief Commercial Officer at Weave, will be speaking at the Precision Drug Discovery & Preclinical Summit (PDDP) San Diego 2025, a leading event bringing together R&D and regulatory professionals to explore cutting-edge advances in preclinical development, translational science, and digital tools. Join us in San Diego to learn how AI is transforming regulatory writing at the earliest stages of drug development.

Talk Details
Title: AI-Assisted Regulatory Writing: Findings from a Top 20 Pharma Case Study
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: Thursday, October 17, 2025
Time: 2:30 PM
Location: San Diego Marriott La Jolla, La Jolla, CA
Event Website: events.precision-globe.com

Session Overview
This session presents final, unpublished findings from a real-world collaboration between Weave and a Top 20 global pharmaceutical company. The study compared traditional regulatory writing with AI-assisted drafting using data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, which are known for their analytical and narrative complexity.

The results revealed measurable time savings and improvements in quality, particularly in drafting, refinement, and data verification. The session will also introduce a practical framework for evolving regulatory processes while maintaining scientific integrity and human oversight.

Key Takeaways:

• A side-by-side comparison of human-only vs. AI-augmented drafting
• A structured framework to evaluate speed and quality
• Actionable insights for applying AI in regulatory workflows without compromising rigor

Attendees will walk away with an evidence-based view of how generative AI can support regulatory teams in early development phases without replacing scientific judgment.

Visit the Weave Booth
Stop by our exhibit table to meet the Weave team and see a live demo of The Weave Platform, our AI-native solution built to accelerate document development, structure complex data, and streamline regulatory readiness from preclinical stages onward.

Whether you’re rethinking your early-stage submission strategy or exploring new digital tools to scale your team’s impact, we’d love to connect.

Join Weave at Fierce Biotech Week – Lindsay Mateo Shares Evidence-Based Insights on AI-Augmented Regulatory Drafting

We’re excited to announce that Lindsay Mateo, Head of Strategic Initiatives at Weave, will be speaking at Fierce Biotech Week, a key gathering of innovators shaping the future of life sciences. Join us at the Encore Boston Harbor Convention & Event Center, A WYNN RESORT, to explore how AI is being applied pragmatically in regulatory practice.

Talk Details

Title: Unpublished Results: Comparing Traditional and AI-Augmented Regulatory Drafting
Speaker: Lindsay Mateo, Head of Strategic Initiatives, Weave
Date: Monday, October 7, 2025
Time: 2:00 PM
Location: Encore Boston Harbor Convention & Event Center, A WYNN RESORT – Boston, MA

Session Overview

This session unveils final, unpublished findings from a groundbreaking collaboration between Weave and a Top 20 global pharmaceutical company. The study compared traditional regulatory writing with AI-assisted drafting using real-world data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, known for their complexity and criticality.

Attendees will walk away with a pragmatic, evidence-based perspective on how AI tools can support—not replace—human expertise in regulatory science.

Learning Objectives:

• Compare speed and quality across human-only and AI-augmented drafting
• Apply a structured framework to evaluate AI tools in real regulatory contexts
• Identify practical use cases for AI in drafting without compromising scientific integrity

Visit the Weave Booth – #212

Stop by Booth 212 to meet the Weave team and see a live demo of The Weave Platform in action. Learn how Weave’s AI-native solution is helping regulatory teams accelerate content development, streamline workflows, and maintain control throughout the submission lifecycle.

Whether you’re evaluating tools or actively building a future-ready regulatory platform, we’d love to connect.

Join Weave at RAPS Convergence 2025 – Brandon Rice Shares Lessons from AI in Regulatory Workflows

We’re excited to announce that Brandon Rice, Chief Product Officer at Weave, will be speaking at RAPS Convergence 2025, the regulatory affairs community’s leading annual event for global healthcare product professionals. Join us in Phoenix to explore forward-thinking solutions shaping the future of regulatory practice.

Talk Details
Title: Lessons from a Comparative Analysis of Old and New Regulatory Processes
Speaker: Brandon Rice, Chief Product Officer, Weave
Date: Wednesday, October 8, 2025
Time: 11:20 AM
‍

Session Overview
What happens when regulatory drafting is optimized with AI? In this session, Brandon will present findings from a real-world collaboration with a Top 20 pharmaceutical company that compared traditional regulatory content development with AI-augmented drafting using a comprehensive toolset.

The results showed significant time savings and measurable gains in quality across drafting, content refinement, and data verification. The session will also offer a practical framework for modernizing regulatory lifecycle management while emphasizing the continued value of human expertise.

Learning Objectives:

1. Identify immediate areas to incorporate AI assistance in regulatory workflows
2. Leverage quality measures to evaluate AI tools in the market today
3. Use the shared framework to set expectations for any future technology adoption

Attendees will gain a grounded, strategic perspective on how AI tools can improve—not replace—scientific and regulatory judgment.

Visit the Weave Booth
Stop by Booth 421 to meet the Weave team and see a live demo of The Weave Platform in action. Learn how Weave’s AI-native solution is helping regulatory teams across the industry accelerate content development, streamline workflows, and maintain control throughout the submission lifecycle.

Whether you’re evaluating tools or actively building a future-ready regulatory platform, we’d love to connect.

Meet Daniel Pointing at SOCRA 2025 — Explore Regulatory-First AI in Action

We’re excited to share that Weave will be joining the Society of Clinical Research Associates (SOCRA) at their 2025 Annual Conference — the go‑to event for clinical research professionals, offering expert-led sessions, interactive workshops, peer‑driven poster programs, and rich networking opportunities

Event Details
Representative: Daniel Pointing, Associate Director, Business Development, Weave
Exhibit Dates: Friday, September 26 – Sunday, September 28, 2025 ‍
Location: Hyatt Regency Chicago, Chicago, IL
Event Website: SOCRA Annual Conference — [https://www.socra.org/annual-conference/2025/2025-annual-conference-information/

Visit the Weave Booth

Swing by our booth to meet Daniel Pointing and discover how Weave’s platform—purpose-built for regulatory workflows—can transform your documentation process with speed, precision, and confidence.

What we’ll showcase:

• How AI-native design (not just repurposed) enables seamless production of safety narratives, clinical study reports, and more
• Real-world strategies for slashing turnaround times on high-volume regulatory deliverables
• A look at maintaining rigorous traceability, auditability, and expert oversight in AI-powered workflows

Whether you’re modernizing systems or scaling for global regulatory safety programs, come connect with Daniel to see how Weave supports your goals.

Join Weave at NACCT 2025 and Explore The Weave Platform

We’re pleased to share that Weave will be present at the North American Congress of Clinical Toxicology (NACCT) 2025, the premier clinical toxicology gathering bringing together experts across healthcare, academia, poison centers, and regulatory bodies. Join us in Chicago to discover how AI-driven automation is redefining regulatory documentation workflows.

Event Details
Representative: Taylor Zeigler, Account Executive, Weave
Exhibit Dates: Friday, September 19 – Sunday, September 21, 2025
Location: Swissôtel Chicago, Chicago, IL ‍
Event Website: clintox.org/nacct

Visit the Weave Booth
Drop by our exhibit space to meet Taylor Zeigler and discover The Weave Platform—an AI-native solution built to streamline the creation of complex regulatory documents, including safety narratives, clinical study reports, and more.

We’ll share insights on:

• How teams in clinical toxicology and safety-focused workflows can automate document drafting without sacrificing quality
• Methods to significantly reduce turnaround time for high-volume deliverables
• What achievable traceability, precision, and expert oversight look like in AI-assisted environments

Whether you’re scaling up for large regulatory safety programs or modernizing workflows, we look forward to connecting and exploring how Weave can support your goals.

Join Weave at DPHARM 2025 – See How AI is Changing the Way We Build Regulatory Documents

We’re excited to share that Weave will be taking the stage at the 2025 DPHARM conference—a premier event spotlighting innovation in clinical development and R&D. DPHARM brings together top minds across pharma, biotech, and technology to challenge the status quo and accelerate smarter drug development.

Talk Details
Title: AI-Assisted Regulatory Writing: Findings from a Top 20 Pharma Case Study
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: September 17, 2025
Time: 1:55 – 2:05 PM Eastern Time
Location: The Westin Copley Place, Boston, MA
Event Website: dpharmconference.com

Session Overview
This session unveils final, unpublished findings from a groundbreaking collaboration between Weave and a Top 20 global pharmaceutical company. The study compares traditional regulatory writing with AI-assisted drafting using real-world data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, known for their complexity and criticality.

Key Takeaways:

• A side-by-side comparison of human-only vs. AI-augmented drafting
• A structured framework to evaluate speed and quality
• Actionable insights for applying AI in regulatory workflows—without compromising scientific integrity

Attendees will walk away with a pragmatic, evidence-based perspective on how AI tools can support—not replace—human expertise in regulatory science.

Visit the Weave Booth #408
Stop by our exhibit table to connect with the Weave team, including CCO Lindsay Mateo and Daniel Pointing, ADBD.
You’ll get a live demo of The Weave Platform, our AI-native solution that’s helping top pharma teams streamline content development and lifecycle management for regulatory submissions.

Whether you’re curious about where AI fits into your regulatory ecosystem or ready to modernize outdated workflows, we’d love to hear from you.

Let’s weave together the future of regulatory writing—see you at DPHARM!